Paediatric Covaxin: Bharat Biotech completes phase 2/3 trials of vaccine

Bharat Biotech has completed Phase 2/3 trials of Covid-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the DCGI

from Latest News https://ift.tt/3lICjfA
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share